Literature DB >> 3692577

PHA- and Con A-induced chemiluminescence of human blood mononuclear cells and granulocytes in luminol or lucigenin.

K Merétey1, M Antal, Z Rozsnyay, U Böhm, E Elekes, G Genti.   

Abstract

Phytohemagglutinin (PHA) and concanavalin A (Con A) can evoke a chemiluminescence (CL) response both in granulocytes and blood mononuclear cells. We have used two parallel systems to compare the quantity and quality of oxygen radicals produced during activation. While the luminol-enhanced CL response is linked to the myeloperoxidase-H2O2-chloride system, the lucigenin-dependent light production measures only the superoxide radical. PHA produced higher CL response in the presence of luminol than with lucigenin. Con A showed high CL response only in the lucigenin-enhanced system. The results suggest that while Con A induces mostly superoxide production, the membrane stimulus evoked by PHA produces light through the myeloperoxidase-H2O2-halide system. Granulocytes are less sensitive to PHA than the blood mononuclear cells. The sensitivity of the responses to several scavengers and enzymes support the differential production of oxygen radicals following activation via these two lectins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3692577     DOI: 10.1007/bf00915985

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

1.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

Review 2.  The secretory code of the neutrophil.

Authors:  G Weissmann; H M Korchak; H D Perez; J E Smolen; I M Goldstein; S T Hoffstein
Journal:  J Reticuloendothel Soc       Date:  1979-12

3.  Affinity of phytohemagglutinin (PHA) isolectins for serum proteins and regulation of the lectin-induced lymphocyte transformation.

Authors:  C Glad; C A Borrebaeck
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

4.  Chemiluminescence and immune cell activation: general features of the thymocyte chemiluminescent responses to plant lectins.

Authors:  B K Mookerjee; E Ferber; M Ernst; N Sharon; H Fischer
Journal:  Immunol Commun       Date:  1980

5.  Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescence.

Authors:  E P Brestel
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

6.  Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  G Briheim; O Stendahl; C Dahlgren
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes.

Authors:  I Minkenberg; E Ferber
Journal:  J Immunol Methods       Date:  1984-06-08       Impact factor: 2.303

8.  In vitro determination of phagocyte activity by luminol- and lucigenin-amplified chemiluminescence.

Authors:  R Müller-Peddinghaus
Journal:  Int J Immunopharmacol       Date:  1984

9.  Effect of indomethacin on human neutrophil chemiluminescence and microbicidal activity.

Authors:  T D Horan; A A Noujaim; T A McPherson
Journal:  Immunopharmacology       Date:  1983-08

10.  Regulation of the growth and differentiation of a human monocytic cell line by lymphokines. I. Induction of superoxide anion production and chemiluminescence.

Authors:  L T Clement; J E Lehmeyer
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

View more
  2 in total

1.  Enhancement of normal neutrophil chemiluminescence by chronic granulomatous disease neutrophils.

Authors:  R L Roberts; B J Ank; E R Stiehm
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

2.  Drugs effects on superoxide generation and chemiluminescence response of human leukocytes.

Authors:  C Pascual; R González; C Romay
Journal:  Agents Actions       Date:  1991-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.